Bio Pharma Dive
JULY 27, 2023
GSK expects its respiratory syncytial virus vaccine will be a multibillion dollar product. But at the beginning it’s predicting a slower launch than for its fast-selling shingles shot.
Pharmaceutical Technology
JULY 27, 2023
GSK has reported an adjusted operating profit of £2.17bn in Q2 2023, which is an almost 8% increase from the £2.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JULY 27, 2023
The results showed that enrollees who’d already lost weight after diet and exercise shed pounds after receiving Mounjaro, while those who stopped treatment gained weight back.
Rethinking Clinical Trials
JULY 27, 2023
Leaders of the NIH Pragmatic Trials Collaboratory hosted an onboarding meeting for the program’s 3 newest Demonstration Projects. The projects joined the program under the UG3 cooperative agreement mechanism to support a 1-year planning phase in preparation for potential transition to a UH3 implementation phase. Access the complete materials from the onboarding session.
Bio Pharma Dive
JULY 27, 2023
The pharma said its latest shot, which covers 21 strains of bacteria, cleared two Phase 3 trials and in some cases spurred a stronger immune response than Pfizer’s Prevnar 20.
Pharmaceutical Technology
JULY 27, 2023
Working in an industry with regular cross-border manufacturing and dealing with a global network of clients means adaptability is vital to maintaining good communications, building relationships, and managing teams effectively.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JULY 27, 2023
In the global pharmaceutical industry, there were 7 private equity deals announced in Q2 2023, worth a total value of $950m, according to GlobalData's Deals Database.
Bio Pharma Dive
JULY 27, 2023
Medicxi is the latest biotech investor to announce a new investment fund in 2023, despite a turbulent market that’s challenged many startups.
Pharmaceutical Technology
JULY 27, 2023
The Asia-Pacific pharma industry experienced a 4% drop in hiring activity in Q2 2023, led by Syngene International's 10% share, according to GlobalData
Antidote
JULY 27, 2023
Before any new therapy can be put on the market, it must be tested to ensure its safety and effectiveness, and the research for this process is done through clinical trials. Clinical trials evaluate new drugs, devices, packaging, and behaviors in order to determine if these potential therapies work for particular conditions or patient populations.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
JULY 27, 2023
The Asia-Pacific pharma industry experienced a 4% drop in hiring activity in Q2 2023, led by Syngene International's 10% share, according to GlobalData
Outsourcing Pharma
JULY 27, 2023
The EMA organized a task force made up of various stakeholders to gather insights on potential EU-level actions to improve the set up of clinical trials during public health emergencies.
Pharmaceutical Technology
JULY 27, 2023
The global pharmaceutical industry recorded a 11% drop in precision and personalized medicine hiring activity in Q2 2023, according to GlobalData
XTalks
JULY 27, 2023
Last week, the US Food and Drug Administration (FDA) stood by its decision, denying a petition asking it to reevaluate the use of eight ortho-phthalates in food-contacting packaging materials. The agency also declined demands to overturn five earlier approvals regarding five distinct ortho-phthalates, alleged to significantly risk human health by leaching into food and beverage products.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
JULY 27, 2023
AbbVie has expanded its strategic collaboration with Calibr for the advancement of multiple preclinical and early-stage clinical assets.
Pharma Marketing Network
JULY 27, 2023
Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceutical companies, and medical device manufacturers alike. These partnerships not only improve patient outcomes but also foster mutual trust and collaboration. In this blog, we will explore five effective strategies to enhance your relationship-building efforts with HCPs and ultimately achieve better healthcare outcomes.
Pharmaceutical Technology
JULY 27, 2023
The UK MHRA has launched a probe into the use of Novo Nordisk’s GLP-1 receptor agonists for diabetes and a weight-loss treatment.
Drug Patent Watch
JULY 27, 2023
Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity of Drugs Approved 2010–2019 and the Public Interest Protections of… The post DrugPatentWatch reveals NIH funding for patents appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
JULY 27, 2023
Nexo Therapeutics, a new small molecule oncology company, has raised $60m in a Series A financing round to support its platform
Fierce Pharma
JULY 27, 2023
Eli Lilly continues to bolster the case for its dual GIP/GLP-1 agonist tirzepatide as a powerful weight loss agent. | Also known as Mounjaro in its approved type 2 diabetes indication, tirzepatide helped patients across two trials—Surmount-3 and Surmount-4—lose up to 26.6% of their body weight, Lilly said Thursday.
Pharmaceutical Technology
JULY 27, 2023
In the global pharmaceutical industry, there were 2 private equity deals announced in Q2 2023, worth a total value of $11.1m, according to GlobalData's Deals Database.
Fierce Pharma
JULY 27, 2023
To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.” | To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.” Approved by the FDA in January 2022, Vabysmo already crossed the one-billion-dollar sales mark in the first half of 2023.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharmaceutical Technology
JULY 27, 2023
In the global pharmaceutical industry, there were 6 M&A deals announced in Q2 2023, worth a total value of $220.2m, according to GlobalData's Deals Database.
Outsourcing Pharma
JULY 27, 2023
Columbia University is running three separate efforts to improve diversity within clinical trials, and it released data showing that early improvements could be seen.
Pharmaceutical Technology
JULY 27, 2023
In the global pharmaceutical industry, there were 17 M&A deals announced in Q2 2023, worth a total value of $1.1bn, according to GlobalData's Deals Database.
Pharma Times
JULY 27, 2023
New HSCC document deems the UK’s vaccination position to be at risk - News - PharmaTimes
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
JULY 27, 2023
In the global pharmaceutical industry, there were 6 M&A deals announced in Q2 2023, worth a total value of $191.2m, according to GlobalData's Deals Database.
Pharma Times
JULY 27, 2023
OCTP aims to demonstrate the lead candidate’s safety, tolerability and pharmacokinetic profile - News - PharmaTimes
Pharmaceutical Technology
JULY 27, 2023
In the global pharmaceutical industry, there were 5 M&A deals announced in Q2 2023, worth a total value of $13.9m, according to GlobalData's Deals Database.
Fierce Pharma
JULY 27, 2023
Daiichi Sankyo's FLT3 inhibitor overcame FDA rejection to win an approval. Astellas signed another protein degrader deal, this time with PeptiDream. | Daiichi Sankyo's FLT3 inhibitor has overcome an FDA rejection to win an approval. Astellas signed another protein degrader deal. Takeda's enzyme replacement therapy flunked a mid-stage trial in a rare neurological disorder.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
246 
Let's personalize your content